Lab News

Watch Out!

Watch Out!  Incredible breakthroughs in Science are breaking through this door.

How-to-guide to use Cas9 RNP for high efficiency genome editing

IGI Project Scientist Mark DeWitt and Scientific Director Jacob Corn have published a paper ” Genome editing via delivery of Cas9 ribonucleoprotein...

READ MORE

IGI Project Scientist Mark DeWitt and Scientific Director Jacob Corn have published a paper ” Genome editing via delivery of Cas9 ribonucleoprotein” with our collaborator Professor Dana Carroll in Methods recently.  This is a how-to guide for how to use the Cas9 RNP for high efficiency genome editing. It walks the reader through experimental design, the editing workflow itself, and analysis of edited cells.

X Close

Diane Ferris went to the March For Science in Washington

Diane Ferris and her son, Charlie Ferris Weiler were interviewed by the AAAS for their attendance at the March For Science in Washington.  She joined...

READ MORE

Diane Ferris and her son, Charlie Ferris Weiler were interviewed by the AAAS for their attendance at the March For Science in Washington.  She joined the march in support of science while setting an example for her family.  

X Close

Amos Liang receives grant from BrightFocus Foundation to study Alzheimer’s disease

Our postdoctoral fellow Amos Jin Rui Liang will receive $100,000.00 grant from the BrightFocus Foundation for his study of Alzheimer’s...

READ MORE

Our postdoctoral fellow Amos Jin Rui Liang will receive $100,000.00 grant from the BrightFocus Foundation for his study of Alzheimer’s disease focusing on the “Identification of Novel ER-phagy Proteins that are Implicated in Neurodegeneration” 

X Close

#1 spot in the Media Highlights: The 10 Essential Stories of 2016

The top UC Berkeley story last year features our postdoctoral fellow Mark Dewitt using the CRISPR-Cas9 gene-editing tool to cure the sickle cell disease.  ...

READ MORE

The top UC Berkeley story last year features our postdoctoral fellow Mark Dewitt using the CRISPR-Cas9 gene-editing tool to cure the sickle cell disease.  The #1 spot in the Media Highlights: The 10 Essential Stories of 2016.  His work was also picked up by dozens of sources, including the Los Angeles Times, Mercury News, Nature, The Scientist, Cosmos Magazine, and GenomeWeb. Roxanne Makasdjian and Stephen McNally produced a video that accompanied the press release and many versions of the story. 

X Close

Welcome, Jonathan Vu!

We're delighted to welcome Jonathan to join our lab as a Research Associate.  He has been working as a volunteer before and will continue to work with Mark DeWitt in the sickle cell research project.

Thomas Barnes from Intellia Therapeutics gave a talk to Corn Lab

The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative...

READ MORE

The management and research teams from Intellia Therapeutics came to visit UC Berkeley today. Thomas Barnes, Ph.D., the Senior Vice President of Innovative Sciences & eXtellia, and his teams shared their scientific expertise in CRISPR/Cas9 technology and clinical development experience to the members in Corn lab.

X Close

Benjamin Gowen will attend the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference

Corn Lab post-doc Benjamin Gowen is attending the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference in Whistler, British Columbia...

READ MORE

Corn Lab post-doc Benjamin Gowen is attending the 2017 Immune Regulation in Autoimmunity and Cancer Keystone Conference in Whistler, British Columbia from March 26-30, 2017.  If you’re attending the meeting, you should come by poster #1030 to see his work on the discovery of an autoimmunity-associated IL2RA enhancer. 

X Close

FILTERS

Tweets

Contact Us

Questions and/or comments about Corn Lab and its activities may be addressed to:

JCORN@BERKELEY.EDU

Share: